TECTONIC THERAPEUTIC, INC. Line of Credit Facility, Maximum Borrowing Capacity
TECTONIC THERAPEUTIC, INC. (TECX) had Line of Credit Facility, Maximum Borrowing Capacity of $10.00 million as of 2017-06-23, per its 10-K filed 2020-03-16.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2020-03-16
- 2017-06-23: Line of Credit Facility, Maximum Borrowing Capacity $10.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2017-06-23 | $10.00M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |